nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Olsalazine—IFNG—Graves' disease	0.0349	1	CrCbGaD
Sulfasalazine—ACAT1—connective tissue—Graves' disease	0.0336	0.0659	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—Graves' disease	0.0281	0.0551	CbGeAlD
Sulfasalazine—SLC46A1—eye—Graves' disease	0.026	0.0509	CbGeAlD
Sulfasalazine—ACAT1—adipose tissue—Graves' disease	0.0258	0.0505	CbGeAlD
Sulfasalazine—CHUK—connective tissue—Graves' disease	0.025	0.0491	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—Graves' disease	0.0235	0.0461	CbGeAlD
Sulfasalazine—ACAT1—thyroid gland—Graves' disease	0.0223	0.0437	CbGeAlD
Sulfasalazine—TBXAS1—adipose tissue—Graves' disease	0.0215	0.0422	CbGeAlD
Sulfasalazine—SLC46A1—pituitary gland—Graves' disease	0.0193	0.0378	CbGeAlD
Sulfasalazine—CHUK—adipose tissue—Graves' disease	0.0192	0.0377	CbGeAlD
Sulfasalazine—TBXAS1—thyroid gland—Graves' disease	0.0187	0.0366	CbGeAlD
Sulfasalazine—PLA2G1B—pituitary gland—Graves' disease	0.0181	0.0355	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—Graves' disease	0.017	0.0334	CbGeAlD
Sulfasalazine—SLC46A1—thyroid gland—Graves' disease	0.0166	0.0326	CbGeAlD
Sulfasalazine—CHUK—thyroid gland—Graves' disease	0.0166	0.0326	CbGeAlD
Sulfasalazine—SLC7A11—adipose tissue—Graves' disease	0.0158	0.031	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—Graves' disease	0.0141	0.0276	CbGeAlD
Sulfasalazine—SLC7A11—thyroid gland—Graves' disease	0.0137	0.0268	CbGeAlD
Sulfasalazine—IKBKB—pituitary gland—Graves' disease	0.0131	0.0257	CbGeAlD
Sulfasalazine—IKBKB—adipose tissue—Graves' disease	0.0131	0.0256	CbGeAlD
Sulfasalazine—IKBKB—thyroid gland—Graves' disease	0.0113	0.0222	CbGeAlD
Sulfasalazine—ALOX5—adipose tissue—Graves' disease	0.0108	0.0212	CbGeAlD
Sulfasalazine—PPARG—connective tissue—Graves' disease	0.0106	0.0208	CbGeAlD
Sulfasalazine—ALOX5—thyroid gland—Graves' disease	0.00936	0.0184	CbGeAlD
Sulfasalazine—PPARG—adipose tissue—Graves' disease	0.00812	0.0159	CbGeAlD
Sulfasalazine—PPARG—thyroid gland—Graves' disease	0.00703	0.0138	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—Graves' disease	0.00566	0.0111	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—Graves' disease	0.00541	0.0106	CbGeAlD
Sulfasalazine—ABCG2—pituitary gland—Graves' disease	0.00523	0.0103	CbGeAlD
Sulfasalazine—ABCG2—adipose tissue—Graves' disease	0.00521	0.0102	CbGeAlD
Sulfasalazine—CYP3A5—adipose tissue—Graves' disease	0.00483	0.00948	CbGeAlD
Sulfasalazine—ABCG2—thyroid gland—Graves' disease	0.00451	0.00884	CbGeAlD
Sulfasalazine—PTGS1—pituitary gland—Graves' disease	0.00436	0.00855	CbGeAlD
Sulfasalazine—PTGS1—adipose tissue—Graves' disease	0.00434	0.00851	CbGeAlD
Sulfasalazine—PTGS2—pituitary gland—Graves' disease	0.00417	0.00817	CbGeAlD
Sulfasalazine—PTGS2—adipose tissue—Graves' disease	0.00415	0.00814	CbGeAlD
Sulfasalazine—PTGS1—thyroid gland—Graves' disease	0.00376	0.00737	CbGeAlD
Sulfasalazine—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.00265	0.00581	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling—HLA-DQB1—Graves' disease	0.00265	0.00581	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.00257	0.00564	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—GC—Graves' disease	0.00253	0.00555	CbGpPWpGaD
Sulfasalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—Graves' disease	0.00246	0.0054	CbGpPWpGaD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00245	0.00538	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00244	0.00537	CbGpPWpGaD
Sulfasalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.0024	0.00528	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.0024	0.00527	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.0024	0.00527	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00232	0.0051	CbGpPWpGaD
Sulfasalazine—CHUK—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.00225	0.00495	CbGpPWpGaD
Sulfasalazine—CHUK—IL1-mediated signaling events—IL1B—Graves' disease	0.00225	0.00494	CbGpPWpGaD
Sulfasalazine—CHUK—Canonical NF-kappaB pathway—TNF—Graves' disease	0.00223	0.0049	CbGpPWpGaD
Sulfasalazine—CHUK—EBV LMP1 signaling—TNF—Graves' disease	0.00223	0.0049	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00222	0.00489	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling—HLA-DRB1—Graves' disease	0.00222	0.00488	CbGpPWpGaD
Sulfasalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00215	0.00473	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.0021	0.00462	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream TCR signaling—CD4—Graves' disease	0.00209	0.0046	CbGpPWpGaD
Sulfasalazine—IKBKB—Type II diabetes mellitus—TNF—Graves' disease	0.00209	0.0046	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00207	0.00456	CbGpPWpGaD
Sulfasalazine—IKBKB—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.00204	0.00449	CbGpPWpGaD
Sulfasalazine—IKBKB—IL1-mediated signaling events—IL1B—Graves' disease	0.00204	0.00448	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.00203	0.00446	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—IFNG—Graves' disease	0.00203	0.00445	CbGpPWpGaD
Sulfasalazine—IKBKB—Canonical NF-kappaB pathway—TNF—Graves' disease	0.00202	0.00444	CbGpPWpGaD
Sulfasalazine—IKBKB—EBV LMP1 signaling—TNF—Graves' disease	0.00202	0.00444	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling—HLA-DRB1—Graves' disease	0.00201	0.00442	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-1 signaling—IL1B—Graves' disease	0.00197	0.00433	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.00197	0.00433	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—CD8A—Graves' disease	0.00194	0.00427	CbGpPWpGaD
Sulfasalazine—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.00194	0.00426	CbGpPWpGaD
Sulfasalazine—CHUK—NOD pathway—IL1B—Graves' disease	0.00193	0.00425	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—FASLG—Graves' disease	0.00193	0.00424	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—B3GNT2—Graves' disease	0.00191	0.00421	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—GC—Graves' disease	0.00191	0.00421	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream TCR signaling—CD4—Graves' disease	0.0019	0.00417	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00188	0.00413	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—FAS—Graves' disease	0.00186	0.00409	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.00184	0.00404	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00181	0.00398	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—IL1B—Graves' disease	0.00181	0.00397	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-1 signaling—IL1B—Graves' disease	0.00179	0.00393	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—CD8A—Graves' disease	0.00176	0.00387	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—FAS—Graves' disease	0.00176	0.00387	CbGpPWpGaD
Sulfasalazine—IKBKB—NOD pathway—IL1B—Graves' disease	0.00175	0.00385	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—FASLG—Graves' disease	0.00175	0.00385	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.00173	0.00381	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.00169	0.00372	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—FAS—Graves' disease	0.00169	0.00371	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—GC—Graves' disease	0.00167	0.00368	CbGpPWpGaD
Sulfasalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.00167	0.00367	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00166	0.00365	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00164	0.00361	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.00164	0.00361	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HLA-E—Graves' disease	0.00162	0.00357	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00162	0.00356	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—FAS—Graves' disease	0.0016	0.00351	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.00158	0.00348	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling—CD4—Graves' disease	0.00157	0.00344	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.00154	0.00338	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—IL1B—Graves' disease	0.00153	0.00336	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-E—Graves' disease	0.00153	0.00336	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—B3GNT2—Graves' disease	0.00151	0.00333	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL2RA—Graves' disease	0.00151	0.00333	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00147	0.00323	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—B3GNT2—Graves' disease	0.00145	0.00319	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.00143	0.00314	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling—CD4—Graves' disease	0.00142	0.00312	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—FAS—Graves' disease	0.0014	0.00307	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—GC—Graves' disease	0.0014	0.00307	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—IL1B—Graves' disease	0.00139	0.00305	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—TNF—Graves' disease	0.00138	0.00302	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00138	0.00302	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL2RA—Graves' disease	0.00137	0.00302	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—TNF—Graves' disease	0.00131	0.00288	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.0013	0.00285	CbGpPWpGaD
Sulfasalazine—CHUK—TNF receptor signaling pathway —TNF—Graves' disease	0.00128	0.00281	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00128	0.0028	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—B3GNT2—Graves' disease	0.00127	0.00279	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—TNF—Graves' disease	0.00125	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—IL1B—Graves' disease	0.00119	0.00262	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —TNF—Graves' disease	0.00116	0.00255	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.00115	0.00254	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—CD4—Graves' disease	0.00112	0.00245	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00111	0.00244	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.0011	0.00241	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.00109	0.0024	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-B—Graves' disease	0.00109	0.00239	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00108	0.00238	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—IL1B—Graves' disease	0.00108	0.00238	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—B3GNT2—Graves' disease	0.00106	0.00233	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.00106	0.00233	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL1B—Graves' disease	0.00103	0.00227	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00102	0.00224	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—CD4—Graves' disease	0.00101	0.00222	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00101	0.00221	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—FASLG—Graves' disease	0.00101	0.00221	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.001	0.0022	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GC—Graves' disease	0.00099	0.00218	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—FAS—Graves' disease	0.000987	0.00217	CbGpPWpGaD
Sulfasalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—Graves' disease	0.000974	0.00214	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—FAS—Graves' disease	0.00097	0.00213	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000965	0.00212	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000964	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.00096	0.00211	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000958	0.00211	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—IL2RA—Graves' disease	0.000944	0.00207	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL1B—Graves' disease	0.000935	0.00205	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000933	0.00205	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000916	0.00201	CbGpPWpGaD
Sulfasalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000903	0.00198	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1B—Graves' disease	0.000891	0.00196	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000887	0.00195	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000878	0.00193	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000846	0.00186	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.00084	0.00184	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1B—Graves' disease	0.000808	0.00178	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000791	0.00174	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TNF—Graves' disease	0.000791	0.00174	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.000783	0.00172	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000765	0.00168	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000761	0.00167	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000758	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IFIH1—Graves' disease	0.000754	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000754	0.00166	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—B3GNT2—Graves' disease	0.00075	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000735	0.00162	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000728	0.0016	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.000725	0.00159	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TNF—Graves' disease	0.000717	0.00158	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000717	0.00158	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000709	0.00156	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000707	0.00155	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000699	0.00154	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000699	0.00154	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000697	0.00153	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IFIH1—Graves' disease	0.000684	0.0015	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000684	0.0015	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000677	0.00149	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000667	0.00146	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.00066	0.00145	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000641	0.00141	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000638	0.0014	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000634	0.00139	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.000622	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000614	0.00135	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GC—Graves' disease	0.000613	0.00135	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HLA-A—Graves' disease	0.000613	0.00135	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000613	0.00135	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—TNF—Graves' disease	0.000594	0.0013	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-E—Graves' disease	0.000594	0.0013	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000593	0.0013	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000579	0.00127	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000572	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-E—Graves' disease	0.00057	0.00125	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	0.000568	0.00125	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—IL1B—Graves' disease	0.000567	0.00125	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD40—Graves' disease	0.000557	0.00122	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000556	0.00122	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	0.000551	0.00121	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTLA4—Graves' disease	0.000549	0.00121	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-E—Graves' disease	0.000538	0.00118	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000528	0.00116	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—B3GNT2—Graves' disease	0.000521	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-E—Graves' disease	0.000517	0.00114	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD40—Graves' disease	0.000505	0.00111	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CTLA4—Graves' disease	0.000498	0.00109	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	0.000492	0.00108	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GC—Graves' disease	0.000483	0.00106	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000479	0.00105	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000466	0.00102	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—B3GNT2—Graves' disease	0.000465	0.00102	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000452	0.000993	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	0.000451	0.000991	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GC—Graves' disease	0.000447	0.000982	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFIH1—Graves' disease	0.000439	0.000965	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GC—Graves' disease	0.000429	0.000943	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-B—Graves' disease	0.000423	0.000929	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000423	0.000929	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD8A—Graves' disease	0.000422	0.000928	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000416	0.000914	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TNF—Graves' disease	0.000412	0.000905	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DQB1—Graves' disease	0.00041	0.000901	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.00041	0.0009	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-B—Graves' disease	0.000406	0.000892	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFIH1—Graves' disease	0.000398	0.000875	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CD4—Graves' disease	0.000395	0.000868	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-B—Graves' disease	0.000383	0.000843	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD8A—Graves' disease	0.000383	0.000841	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000377	0.000829	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-A—Graves' disease	0.000376	0.000827	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-B—Graves' disease	0.000368	0.000809	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—B3GNT2—Graves' disease	0.000366	0.000804	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—Graves' disease	0.000357	0.000784	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-E—Graves' disease	0.000346	0.00076	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000344	0.000755	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-A—Graves' disease	0.000341	0.00075	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GC—Graves' disease	0.000341	0.000749	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—B3GNT2—Graves' disease	0.000339	0.000744	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40—Graves' disease	0.000338	0.000742	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTLA4—Graves' disease	0.000333	0.000732	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ICAM1—Graves' disease	0.00033	0.000725	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—B3GNT2—Graves' disease	0.000325	0.000715	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GC—Graves' disease	0.00032	0.000704	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-E—Graves' disease	0.000313	0.000689	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000312	0.000685	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—B3GNT2—Graves' disease	0.000308	0.000678	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40—Graves' disease	0.000306	0.000673	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TSHR—Graves' disease	0.000302	0.000664	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—Graves' disease	0.000302	0.000663	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ICAM1—Graves' disease	0.000299	0.000657	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQB1—Graves' disease	0.000274	0.000603	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TSHR—Graves' disease	0.000274	0.000602	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—B3GNT2—Graves' disease	0.000258	0.000568	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—Graves' disease	0.000256	0.000563	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—Graves' disease	0.000252	0.000555	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQB1—Graves' disease	0.000249	0.000546	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—Graves' disease	0.000246	0.000541	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000243	0.000533	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—B3GNT2—Graves' disease	0.000243	0.000533	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—Graves' disease	0.000242	0.000533	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—Graves' disease	0.000232	0.00051	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2RA—Graves' disease	0.000231	0.000507	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—Graves' disease	0.000229	0.000503	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-A—Graves' disease	0.000228	0.000501	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—Graves' disease	0.000223	0.000491	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—Graves' disease	0.00022	0.000483	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HLA-A—Graves' disease	0.000211	0.000463	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2RA—Graves' disease	0.000209	0.00046	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DRB1—Graves' disease	0.000209	0.000458	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-A—Graves' disease	0.000207	0.000455	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—Graves' disease	0.000204	0.000448	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ICAM1—Graves' disease	0.0002	0.00044	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL10—Graves' disease	0.000195	0.000429	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DRB1—Graves' disease	0.000189	0.000415	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ICAM1—Graves' disease	0.000181	0.000399	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL10—Graves' disease	0.000177	0.000389	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—Graves' disease	0.000152	0.000335	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2RA—Graves' disease	0.000149	0.000328	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—Graves' disease	0.000147	0.000323	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—Graves' disease	0.000138	0.000303	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—Graves' disease	0.000136	0.000298	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—Graves' disease	0.000136	0.000298	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2RA—Graves' disease	0.000135	0.000297	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—Graves' disease	0.000133	0.000293	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—Graves' disease	0.000125	0.000274	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—Graves' disease	0.000123	0.000271	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—Graves' disease	8.04e-05	0.000177	CbGpPWpGaD
